Table 4

Grade summary of findings for Ware et al 201220

OutcomesComparator arm
Transfusions with chelation
Intervention arm
Hydroxyurea with phlebotomy
Relative effect
(95% CI)
No. of participants (studies)Quality of the evidence (GRADE)Comments
Secondary stroke recurrence
recurrence rate
Follow-up: 6 months
Recurrence rate of 0%, 0.0 events per 100 patient years in comparator arm versus recurrence rate of 10%, 5.6 events per 100 patient years in the intervention armRate difference of 0.1161
(1 study)
⊕⊕⊝⊝
low†‡§¶
Iron overload
Liver Iron concentration mg/g dry weight liver
Follow-up: 6 months
The median iron overload in the control groups was
17.3 mg/g dry weight liver (8.8–30.7 IQR)
The median iron overload in the intervention groups was
17.2 mg/g dry weight liver
(10.0–30.6 IQR)
Change from baseline(median (IQR)
−2.2 (−5.5 to 4.9) in the comparator group
−1.2 (−2.8 to 7.2) in the intervention group
161
(1 study)
⊕⊕⊝⊝
low †‡§¶,**,††
  • *Children enrolled in the study were above 5 years old yet interested in data of children below 5 years.

  • †The use of hydroxyurea overlapped at some point with transfusions during the dose escalation.

  • ‡The study setting is in high-income setting where there is thorough laboratory monitoring in contrast with low-income setting that the study question focuses on.

  • §Some point estimates in the study have wide CIs.

  • ¶Sample sizes in both arms were small (hydroxyurea with phlebotomy, n=67; while transfusions with chelation, n=66).

  • GRADE Working Group grades of evidence; High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.

  • GRADE, Grading of Recommendations Assessment, Development and Evaluation.